Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

Parker, WAE, Orme, RC, Hanson, J et al. (11 more authors) (2019) Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets, 30 (2). pp. 148-157. ISSN 0953-7104

Abstract

Metadata

Authors/Creators:
  • Parker, WAE
  • Orme, RC
  • Hanson, J
  • Stokes, HM
  • Bridge, CM
  • Shaw, PA
  • Sumaya, W
  • Thorneycroft, K
  • Petrucci, G
  • Porro, B
  • Judge, HM
  • Ajjan, RA
  • Rocca, B
  • Storey, RF
Copyright, Publisher and Additional Information: © 2019 Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Aspirin; bleeding; P2Y12 inhibitors; thromboxane; ticagrelor
Dates:
  • Published: 17 February 2019
  • Accepted: 11 January 2019
  • Published (online): 13 February 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Clinical & Population Science Dept (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Mar 2019 11:12
Last Modified: 28 Mar 2019 15:25
Status: Published
Publisher: Taylor & Francis
Identification Number: https://doi.org/10.1080/09537104.2019.1572880

Share / Export

Statistics